Literature DB >> 3902490

Elimination of mycoplasmas from cell cultures utilizing hyperimmune sera.

S Jeansson, J E Brorson.   

Abstract

Eighteen cell lines contaminated with various mycoplasmas have been treated with hyperimmune sera and mycoplasmas have been eradicated from all. After treatment the cell lines have been observed for a least one year and they are still free from mycoplasma contamination as ascertained by four independent mycoplasma detection assays. The hyperimmune sera used were of high titer, type-specific and growth-inhibiting. These sera were produced by immunization of rabbits with purified membranes from Mycoplasma orale, M. arginini, M. hominis, M. fermentans, M. hyorhinis and Acholeplasma laidlawii. In addition to elimination of mycoplasmas from cell cultures we have successfully used these sera for detection and typing of mycoplasma contamination in cell cultures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902490     DOI: 10.1016/0014-4827(85)90502-6

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  Use of ciprofloxacin and BM-Cyclin in mycoplasma decontamination.

Authors:  C Somasundaram; W Nicklas; S Matzku
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

2.  Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.

Authors:  K Hellstrand; S Hermodsson
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

3.  Elimination of mycoplasmas from cell cultures by a novel soft agar technique.

Authors:  H Kotani; G Butler; D Heggan; G J McGarrity
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

4.  Treatment of mycoplasma contamination in a large panel of cell cultures.

Authors:  H G Drexler; S M Gignac; Z B Hu; A Hopert; E Fleckenstein; M Voges; C C Uphoff
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-05       Impact factor: 2.416

5.  Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.

Authors:  A Vahlne; P Horal; K Eriksson; S Jeansson; L Rymo; K G Hedström; C Czerkinsky; J Holmgren; B Svennerholm
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.